AustralieFrV1, PascalFrancis, Corpus, bibRecord, 003542

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

Identifieur interne : 003542 ( PascalFrancis/Corpus ); précédent : 003541; suivant : 003543

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

Auteurs : Dedee F. Murrell ; Sarah Dick ; A. R. Ahmed ; Masayuki Amagai ; Maria A. Barnadas ; Luca Borradori ; Jean-Claude Bystryn ; Giuseppe Cianchini ; Luis Diaz ; David Fivenson ; Russell Hall ; Karen E. Harman ; Takashi Hashimoto ; Michael Hertl ; Nico Hunzelmann ; Pilar Iranzo ; Pascal Joly ; Marcel F. Jonkman ; Yasuo Kitajima ; Neil J. Korman ; Linda K. Martin ; Daniel Mimouni ; Amit G. Pandya ; Aimee S. Payne ; David Rubenstein ; Hiroshi Shimizu ; Animesh A. Sinha ; David Sirois ; Detlef Zillikens ; Victoria P. Werth

Source :

Journal of the American Academy of Dermatology [ 0190-9622 ] ; 2008.

RBID : Pascal:08-0281029

Descripteurs français

Pascal (Inist)
- Pemphigus, Définition, Extrémité, Traitement, Dermatologie.

English descriptors

KwdEn :
- Definition, Dermatology, End, Pemphigus, Treatment.

Abstract

Our scientific knowledge of pemphigus has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in pemphigus. A major obstacle in comparing therapeutic outcomes between centers is the lack of generally accepted definitions and measurements for the clinical evaluation of patients with pemphigus. Common terms and end points of pemphigus are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. This consensus statement from the International Pemphigus Committee represents 2 years of collaborative efforts to attain mutually acceptable common definitions for pemphigus. These should assist in development of consistent reporting of outcomes in future studies.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0190-9622`
A02	`01`			`@0 JAADDB`
A03		`1`		`@0 J. Am. Acad. Dermatol.`
A05				`@2 58`
A06				`@2 6`
A08	`01`	`1`	`ENG`	`@1 Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus`
A11	`01`	`1`		`@1 MURRELL (Dedee F.)`
A11	`02`	`1`		`@1 DICK (Sarah)`
A11	`03`	`1`		`@1 AHMED (A. R.)`
A11	`04`	`1`		`@1 AMAGAI (Masayuki)`
A11	`05`	`1`		`@1 BARNADAS (Maria A.)`
A11	`06`	`1`		`@1 BORRADORI (Luca)`
A11	`07`	`1`		`@1 BYSTRYN (Jean-Claude)`
A11	`08`	`1`		`@1 CIANCHINI (Giuseppe)`
A11	`09`	`1`		`@1 DIAZ (Luis)`
A11	`10`	`1`		`@1 FIVENSON (David)`
A11	`11`	`1`		`@1 HALL (Russell)`
A11	`12`	`1`		`@1 HARMAN (Karen E.)`
A11	`13`	`1`		`@1 HASHIMOTO (Takashi)`
A11	`14`	`1`		`@1 HERTL (Michael)`
A11	`15`	`1`		`@1 HUNZELMANN (Nico)`
A11	`16`	`1`		`@1 IRANZO (Pilar)`
A11	`17`	`1`		`@1 JOLY (Pascal)`
A11	`18`	`1`		`@1 JONKMAN (Marcel F.)`
A11	`19`	`1`		`@1 KITAJIMA (Yasuo)`
A11	`20`	`1`		`@1 KORMAN (Neil J.)`
A11	`21`	`1`		`@1 MARTIN (Linda K.)`
A11	`22`	`1`		`@1 MIMOUNI (Daniel)`
A11	`23`	`1`		`@1 PANDYA (Amit G.)`
A11	`24`	`1`		`@1 PAYNE (Aimee S.)`
A11	`25`	`1`		`@1 RUBENSTEIN (David)`
A11	`26`	`1`		`@1 SHIMIZU (Hiroshi)`
A11	`27`	`1`		`@1 SINHA (Animesh A.)`
A11	`28`	`1`		`@1 SIROIS (David)`
A11	`29`	`1`		`@1 ZILLIKENS (Detlef)`
A11	`30`	`1`		`@1 WERTH (Victoria P.)`
A14	`01`			`@1 Departments of Dermatology at St George Hospital, University of NSW @2 Sydney @3 AUS @Z 1 aut. @Z 21 aut.`
A14	`02`			`@1 University of Pennsylvania @3 USA @Z 2 aut. @Z 24 aut. @Z 30 aut.`
A14	`03`			`@1 Department of Medicine, Center for Blistering Diseases, New England Baptist Hospital @2 Boston @3 USA @Z 3 aut.`
A14	`04`			`@1 Keio University School of Medicine @2 Tokyo @3 JPN @Z 4 aut.`
A14	`05`			`@1 Hospital de la Santa Creu i Sant Pau @2 Barcelona @3 ESP @Z 5 aut.`
A14	`06`			`@1 Hôpital Cantonal Universitaire @2 Geneva @3 CHE @Z 6 aut.`
A14	`07`			`@1 New York University Medical Center @3 USA @Z 7 aut.`
A14	`08`			`@1 Immunodermatology Department, Istituto Dermopatico dell'lmmacolata, I.R.C.C.S., Via dei Monti di Creta @2 Rome @3 ITA @Z 8 aut.`
A14	`09`			`@1 University of North Carolina @2 Chapel Hill @3 USA @Z 9 aut. @Z 25 aut.`
A14	`10`			`@1 Private Practice @2 Ann Arbor @3 USA @Z 10 aut.`
A14	`11`			`@1 Division of Dermatology, Duke Medical Center @2 Durham @3 USA @Z 11 aut.`
A14	`12`			`@1 University Hospitals Leicester @3 GBR @Z 12 aut.`
A14	`13`			`@1 Kurume University School of Medicine @3 JPN @Z 13 aut.`
A14	`14`			`@1 Universitätsklinikum GieBen und Marburg GmbH @3 DEU @Z 14 aut.`
A14	`15`			`@1 Universitätshautklinik Köln @3 DEU @Z 15 aut.`
A14	`16`			`@1 Hospital Clínic, Universitat de Barcelona @3 ESP @Z 16 aut.`
A14	`17`			`@1 Clinique Dermatologique, Hopital Charles Nicolle @2 Rouen @3 FRA @Z 17 aut.`
A14	`18`			`@1 University Medical Center Groningen, University of Groningen @3 NLD @Z 18 aut.`
A14	`19`			`@1 Gifu University School of Medicine @3 JPN @Z 19 aut.`
A14	`20`			`@1 University Hospitals Case Medical Center @2 Cleveland @3 USA @Z 20 aut.`
A14	`21`			`@1 Rabin Medical Center @2 Petah-Tikva @3 ISR @Z 22 aut.`
A14	`22`			`@1 University of Texas Southwestern Medical Center @2 Dallas @3 USA @Z 23 aut.`
A14	`23`			`@1 Hokkaido University Graduate School of Medicine @2 Sapporo @3 JPN @Z 26 aut.`
A14	`24`			`@1 Center for Investigative Dermatology, Division of Dermatology and Cutaneous Sciences, Michigan State University @2 East Lansing @3 USA @Z 27 aut.`
A14	`25`			`@1 Department of Oral Medicine, New York University College of Dentistry @3 USA @Z 28 aut.`
A20				`@1 1043-1046`
A21				`@1 2008`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 18387 @5 354000195963870150`
A44				`@0 0000 @1 © 2008 INIST-CNRS. All rights reserved.`
A45				`@0 1 ref.`
A47	`01`	`1`		`@0 08-0281029`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Journal of the American Academy of Dermatology`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Our scientific knowledge of pemphigus has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in pemphigus. A major obstacle in comparing therapeutic outcomes between centers is the lack of generally accepted definitions and measurements for the clinical evaluation of patients with pemphigus. Common terms and end points of pemphigus are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. This consensus statement from the International Pemphigus Committee represents 2 years of collaborative efforts to attain mutually acceptable common definitions for pemphigus. These should assist in development of consistent reporting of outcomes in future studies.
C02	`01`	`X`		`@0 002B08E`
C02	`02`	`X`		`@0 002B01`
C03	`01`	`X`	`FRE`	`@0 Pemphigus @5 01`
C03	`01`	`X`	`ENG`	`@0 Pemphigus @5 01`
C03	`01`	`X`	`SPA`	`@0 Pénfigo @5 01`
C03	`02`	`X`	`FRE`	`@0 Définition @5 09`
C03	`02`	`X`	`ENG`	`@0 Definition @5 09`
C03	`02`	`X`	`SPA`	`@0 Definición @5 09`
C03	`03`	`X`	`FRE`	`@0 Extrémité @5 10`
C03	`03`	`X`	`ENG`	`@0 End @5 10`
C03	`03`	`X`	`SPA`	`@0 Extremidad @5 10`
C03	`04`	`X`	`FRE`	`@0 Traitement @5 11`
C03	`04`	`X`	`ENG`	`@0 Treatment @5 11`
C03	`04`	`X`	`SPA`	`@0 Tratamiento @5 11`
C03	`05`	`X`	`FRE`	`@0 Dermatologie @5 12`
C03	`05`	`X`	`ENG`	`@0 Dermatology @5 12`
C03	`05`	`X`	`SPA`	`@0 Dermatología @5 12`
C07	`01`	`X`	`FRE`	`@0 Maladie autoimmune @5 37`
C07	`01`	`X`	`ENG`	`@0 Autoimmune disease @5 37`
C07	`01`	`X`	`SPA`	`@0 Enfermedad autoinmune @5 37`
C07	`02`	`X`	`FRE`	`@0 Dermatose bulleuse @5 38`
C07	`02`	`X`	`ENG`	`@0 Bullous dermatosis @5 38`
C07	`02`	`X`	`SPA`	`@0 Dermatosis bulosa @5 38`
C07	`03`	`X`	`FRE`	`@0 Pathologie de la peau @5 39`
C07	`03`	`X`	`ENG`	`@0 Skin disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Piel patología @5 39`
C07	`04`	`X`	`FRE`	`@0 Immunopathologie @5 40`
C07	`04`	`X`	`ENG`	`@0 Immunopathology @5 40`
C07	`04`	`X`	`SPA`	`@0 Inmunopatología @5 40`
N21				`@1 175`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 08-0281029 INIST
ET :	Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
AU :	MURRELL (Dedee F.); DICK (Sarah); AHMED (A. R.); AMAGAI (Masayuki); BARNADAS (Maria A.); BORRADORI (Luca); BYSTRYN (Jean-Claude); CIANCHINI (Giuseppe); DIAZ (Luis); FIVENSON (David); HALL (Russell); HARMAN (Karen E.); HASHIMOTO (Takashi); HERTL (Michael); HUNZELMANN (Nico); IRANZO (Pilar); JOLY (Pascal); JONKMAN (Marcel F.); KITAJIMA (Yasuo); KORMAN (Neil J.); MARTIN (Linda K.); MIMOUNI (Daniel); PANDYA (Amit G.); PAYNE (Aimee S.); RUBENSTEIN (David); SHIMIZU (Hiroshi); SINHA (Animesh A.); SIROIS (David); ZILLIKENS (Detlef); WERTH (Victoria P.)
AF :	Departments of Dermatology at St George Hospital, University of NSW/Sydney/Australie (1 aut., 21 aut.); University of Pennsylvania/Etats-Unis (2 aut., 24 aut., 30 aut.); Department of Medicine, Center for Blistering Diseases, New England Baptist Hospital/Boston/Etats-Unis (3 aut.); Keio University School of Medicine/Tokyo/Japon (4 aut.); Hospital de la Santa Creu i Sant Pau/Barcelona/Espagne (5 aut.); Hôpital Cantonal Universitaire/Geneva/Suisse (6 aut.); New York University Medical Center/Etats-Unis (7 aut.); Immunodermatology Department, Istituto Dermopatico dell'lmmacolata, I.R.C.C.S., Via dei Monti di Creta/Rome/Italie (8 aut.); University of North Carolina/Chapel Hill/Etats-Unis (9 aut., 25 aut.); Private Practice/Ann Arbor/Etats-Unis (10 aut.); Division of Dermatology, Duke Medical Center/Durham/Etats-Unis (11 aut.); University Hospitals Leicester/Royaume-Uni (12 aut.); Kurume University School of Medicine/Japon (13 aut.); Universitätsklinikum GieBen und Marburg GmbH/Allemagne (14 aut.); Universitätshautklinik Köln/Allemagne (15 aut.); Hospital Clínic, Universitat de Barcelona/Espagne (16 aut.); Clinique Dermatologique, Hopital Charles Nicolle/Rouen/France (17 aut.); University Medical Center Groningen, University of Groningen/Pays-Bas (18 aut.); Gifu University School of Medicine/Japon (19 aut.); University Hospitals Case Medical Center/Cleveland/Etats-Unis (20 aut.); Rabin Medical Center/Petah-Tikva/Israël (22 aut.); University of Texas Southwestern Medical Center/Dallas/Etats-Unis (23 aut.); Hokkaido University Graduate School of Medicine/Sapporo/Japon (26 aut.); Center for Investigative Dermatology, Division of Dermatology and Cutaneous Sciences, Michigan State University/East Lansing/Etats-Unis (27 aut.); Department of Oral Medicine, New York University College of Dentistry/Etats-Unis (28 aut.)
DT :	Publication en série; Niveau analytique
SO :	Journal of the American Academy of Dermatology; ISSN 0190-9622; Coden JAADDB; Etats-Unis; Da. 2008; Vol. 58; No. 6; Pp. 1043-1046; Bibl. 1 ref.
LA :	Anglais
EA :	Our scientific knowledge of pemphigus has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in pemphigus. A major obstacle in comparing therapeutic outcomes between centers is the lack of generally accepted definitions and measurements for the clinical evaluation of patients with pemphigus. Common terms and end points of pemphigus are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. This consensus statement from the International Pemphigus Committee represents 2 years of collaborative efforts to attain mutually acceptable common definitions for pemphigus. These should assist in development of consistent reporting of outcomes in future studies.
CC :	002B08E; 002B01
FD :	Pemphigus; Définition; Extrémité; Traitement; Dermatologie
FG :	Maladie autoimmune; Dermatose bulleuse; Pathologie de la peau; Immunopathologie
ED :	Pemphigus; Definition; End; Treatment; Dermatology
EG :	Autoimmune disease; Bullous dermatosis; Skin disease; Immunopathology
SD :	Pénfigo; Definición; Extremidad; Tratamiento; Dermatología
LO :	INIST-18387.354000195963870150
ID :	08-0281029

Links to Exploration step

Pascal:08-0281029

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus</title>
<author><name sortKey="Murrell, Dedee F" sort="Murrell, Dedee F" uniqKey="Murrell D" first="Dedee F." last="Murrell">Dedee F. Murrell</name>
<affiliation><inist:fA14 i1="01"><s1>Departments of Dermatology at St George Hospital, University of NSW</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dick, Sarah" sort="Dick, Sarah" uniqKey="Dick S" first="Sarah" last="Dick">Sarah Dick</name>
<affiliation><inist:fA14 i1="02"><s1>University of Pennsylvania</s1>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>24 aut.</sZ>
<sZ>30 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ahmed, A R" sort="Ahmed, A R" uniqKey="Ahmed A" first="A. R." last="Ahmed">A. R. Ahmed</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Medicine, Center for Blistering Diseases, New England Baptist Hospital</s1>
<s2>Boston</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Amagai, Masayuki" sort="Amagai, Masayuki" uniqKey="Amagai M" first="Masayuki" last="Amagai">Masayuki Amagai</name>
<affiliation><inist:fA14 i1="04"><s1>Keio University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Barnadas, Maria A" sort="Barnadas, Maria A" uniqKey="Barnadas M" first="Maria A." last="Barnadas">Maria A. Barnadas</name>
<affiliation><inist:fA14 i1="05"><s1>Hospital de la Santa Creu i Sant Pau</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Borradori, Luca" sort="Borradori, Luca" uniqKey="Borradori L" first="Luca" last="Borradori">Luca Borradori</name>
<affiliation><inist:fA14 i1="06"><s1>Hôpital Cantonal Universitaire</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bystryn, Jean Claude" sort="Bystryn, Jean Claude" uniqKey="Bystryn J" first="Jean-Claude" last="Bystryn">Jean-Claude Bystryn</name>
<affiliation><inist:fA14 i1="07"><s1>New York University Medical Center</s1>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Cianchini, Giuseppe" sort="Cianchini, Giuseppe" uniqKey="Cianchini G" first="Giuseppe" last="Cianchini">Giuseppe Cianchini</name>
<affiliation><inist:fA14 i1="08"><s1>Immunodermatology Department, Istituto Dermopatico dell'lmmacolata, I.R.C.C.S., Via dei Monti di Creta</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Diaz, Luis" sort="Diaz, Luis" uniqKey="Diaz L" first="Luis" last="Diaz">Luis Diaz</name>
<affiliation><inist:fA14 i1="09"><s1>University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
<sZ>25 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fivenson, David" sort="Fivenson, David" uniqKey="Fivenson D" first="David" last="Fivenson">David Fivenson</name>
<affiliation><inist:fA14 i1="10"><s1>Private Practice</s1>
<s2>Ann Arbor</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hall, Russell" sort="Hall, Russell" uniqKey="Hall R" first="Russell" last="Hall">Russell Hall</name>
<affiliation><inist:fA14 i1="11"><s1>Division of Dermatology, Duke Medical Center</s1>
<s2>Durham</s2>
<s3>USA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Harman, Karen E" sort="Harman, Karen E" uniqKey="Harman K" first="Karen E." last="Harman">Karen E. Harman</name>
<affiliation><inist:fA14 i1="12"><s1>University Hospitals Leicester</s1>
<s3>GBR</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hashimoto, Takashi" sort="Hashimoto, Takashi" uniqKey="Hashimoto T" first="Takashi" last="Hashimoto">Takashi Hashimoto</name>
<affiliation><inist:fA14 i1="13"><s1>Kurume University School of Medicine</s1>
<s3>JPN</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hertl, Michael" sort="Hertl, Michael" uniqKey="Hertl M" first="Michael" last="Hertl">Michael Hertl</name>
<affiliation><inist:fA14 i1="14"><s1>Universitätsklinikum GieBen und Marburg GmbH</s1>
<s3>DEU</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hunzelmann, Nico" sort="Hunzelmann, Nico" uniqKey="Hunzelmann N" first="Nico" last="Hunzelmann">Nico Hunzelmann</name>
<affiliation><inist:fA14 i1="15"><s1>Universitätshautklinik Köln</s1>
<s3>DEU</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Iranzo, Pilar" sort="Iranzo, Pilar" uniqKey="Iranzo P" first="Pilar" last="Iranzo">Pilar Iranzo</name>
<affiliation><inist:fA14 i1="16"><s1>Hospital Clínic, Universitat de Barcelona</s1>
<s3>ESP</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Joly, Pascal" sort="Joly, Pascal" uniqKey="Joly P" first="Pascal" last="Joly">Pascal Joly</name>
<affiliation><inist:fA14 i1="17"><s1>Clinique Dermatologique, Hopital Charles Nicolle</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>17 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Jonkman, Marcel F" sort="Jonkman, Marcel F" uniqKey="Jonkman M" first="Marcel F." last="Jonkman">Marcel F. Jonkman</name>
<affiliation><inist:fA14 i1="18"><s1>University Medical Center Groningen, University of Groningen</s1>
<s3>NLD</s3>
<sZ>18 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kitajima, Yasuo" sort="Kitajima, Yasuo" uniqKey="Kitajima Y" first="Yasuo" last="Kitajima">Yasuo Kitajima</name>
<affiliation><inist:fA14 i1="19"><s1>Gifu University School of Medicine</s1>
<s3>JPN</s3>
<sZ>19 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Korman, Neil J" sort="Korman, Neil J" uniqKey="Korman N" first="Neil J." last="Korman">Neil J. Korman</name>
<affiliation><inist:fA14 i1="20"><s1>University Hospitals Case Medical Center</s1>
<s2>Cleveland</s2>
<s3>USA</s3>
<sZ>20 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Martin, Linda K" sort="Martin, Linda K" uniqKey="Martin L" first="Linda K." last="Martin">Linda K. Martin</name>
<affiliation><inist:fA14 i1="01"><s1>Departments of Dermatology at St George Hospital, University of NSW</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mimouni, Daniel" sort="Mimouni, Daniel" uniqKey="Mimouni D" first="Daniel" last="Mimouni">Daniel Mimouni</name>
<affiliation><inist:fA14 i1="21"><s1>Rabin Medical Center</s1>
<s2>Petah-Tikva</s2>
<s3>ISR</s3>
<sZ>22 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Pandya, Amit G" sort="Pandya, Amit G" uniqKey="Pandya A" first="Amit G." last="Pandya">Amit G. Pandya</name>
<affiliation><inist:fA14 i1="22"><s1>University of Texas Southwestern Medical Center</s1>
<s2>Dallas</s2>
<s3>USA</s3>
<sZ>23 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Payne, Aimee S" sort="Payne, Aimee S" uniqKey="Payne A" first="Aimee S." last="Payne">Aimee S. Payne</name>
<affiliation><inist:fA14 i1="02"><s1>University of Pennsylvania</s1>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>24 aut.</sZ>
<sZ>30 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rubenstein, David" sort="Rubenstein, David" uniqKey="Rubenstein D" first="David" last="Rubenstein">David Rubenstein</name>
<affiliation><inist:fA14 i1="09"><s1>University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
<sZ>25 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Shimizu, Hiroshi" sort="Shimizu, Hiroshi" uniqKey="Shimizu H" first="Hiroshi" last="Shimizu">Hiroshi Shimizu</name>
<affiliation><inist:fA14 i1="23"><s1>Hokkaido University Graduate School of Medicine</s1>
<s2>Sapporo</s2>
<s3>JPN</s3>
<sZ>26 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sinha, Animesh A" sort="Sinha, Animesh A" uniqKey="Sinha A" first="Animesh A." last="Sinha">Animesh A. Sinha</name>
<affiliation><inist:fA14 i1="24"><s1>Center for Investigative Dermatology, Division of Dermatology and Cutaneous Sciences, Michigan State University</s1>
<s2>East Lansing</s2>
<s3>USA</s3>
<sZ>27 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sirois, David" sort="Sirois, David" uniqKey="Sirois D" first="David" last="Sirois">David Sirois</name>
<affiliation><inist:fA14 i1="25"><s1>Department of Oral Medicine, New York University College of Dentistry</s1>
<s3>USA</s3>
<sZ>28 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Zillikens, Detlef" sort="Zillikens, Detlef" uniqKey="Zillikens D" first="Detlef" last="Zillikens">Detlef Zillikens</name>
</author>
<author><name sortKey="Werth, Victoria P" sort="Werth, Victoria P" uniqKey="Werth V" first="Victoria P." last="Werth">Victoria P. Werth</name>
<affiliation><inist:fA14 i1="02"><s1>University of Pennsylvania</s1>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>24 aut.</sZ>
<sZ>30 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">08-0281029</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 08-0281029 INIST</idno>
<idno type="RBID">Pascal:08-0281029</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003542</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus</title>
<author><name sortKey="Murrell, Dedee F" sort="Murrell, Dedee F" uniqKey="Murrell D" first="Dedee F." last="Murrell">Dedee F. Murrell</name>
<affiliation><inist:fA14 i1="01"><s1>Departments of Dermatology at St George Hospital, University of NSW</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dick, Sarah" sort="Dick, Sarah" uniqKey="Dick S" first="Sarah" last="Dick">Sarah Dick</name>
<affiliation><inist:fA14 i1="02"><s1>University of Pennsylvania</s1>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>24 aut.</sZ>
<sZ>30 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ahmed, A R" sort="Ahmed, A R" uniqKey="Ahmed A" first="A. R." last="Ahmed">A. R. Ahmed</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Medicine, Center for Blistering Diseases, New England Baptist Hospital</s1>
<s2>Boston</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Amagai, Masayuki" sort="Amagai, Masayuki" uniqKey="Amagai M" first="Masayuki" last="Amagai">Masayuki Amagai</name>
<affiliation><inist:fA14 i1="04"><s1>Keio University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Barnadas, Maria A" sort="Barnadas, Maria A" uniqKey="Barnadas M" first="Maria A." last="Barnadas">Maria A. Barnadas</name>
<affiliation><inist:fA14 i1="05"><s1>Hospital de la Santa Creu i Sant Pau</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Borradori, Luca" sort="Borradori, Luca" uniqKey="Borradori L" first="Luca" last="Borradori">Luca Borradori</name>
<affiliation><inist:fA14 i1="06"><s1>Hôpital Cantonal Universitaire</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bystryn, Jean Claude" sort="Bystryn, Jean Claude" uniqKey="Bystryn J" first="Jean-Claude" last="Bystryn">Jean-Claude Bystryn</name>
<affiliation><inist:fA14 i1="07"><s1>New York University Medical Center</s1>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Cianchini, Giuseppe" sort="Cianchini, Giuseppe" uniqKey="Cianchini G" first="Giuseppe" last="Cianchini">Giuseppe Cianchini</name>
<affiliation><inist:fA14 i1="08"><s1>Immunodermatology Department, Istituto Dermopatico dell'lmmacolata, I.R.C.C.S., Via dei Monti di Creta</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Diaz, Luis" sort="Diaz, Luis" uniqKey="Diaz L" first="Luis" last="Diaz">Luis Diaz</name>
<affiliation><inist:fA14 i1="09"><s1>University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
<sZ>25 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fivenson, David" sort="Fivenson, David" uniqKey="Fivenson D" first="David" last="Fivenson">David Fivenson</name>
<affiliation><inist:fA14 i1="10"><s1>Private Practice</s1>
<s2>Ann Arbor</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hall, Russell" sort="Hall, Russell" uniqKey="Hall R" first="Russell" last="Hall">Russell Hall</name>
<affiliation><inist:fA14 i1="11"><s1>Division of Dermatology, Duke Medical Center</s1>
<s2>Durham</s2>
<s3>USA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Harman, Karen E" sort="Harman, Karen E" uniqKey="Harman K" first="Karen E." last="Harman">Karen E. Harman</name>
<affiliation><inist:fA14 i1="12"><s1>University Hospitals Leicester</s1>
<s3>GBR</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hashimoto, Takashi" sort="Hashimoto, Takashi" uniqKey="Hashimoto T" first="Takashi" last="Hashimoto">Takashi Hashimoto</name>
<affiliation><inist:fA14 i1="13"><s1>Kurume University School of Medicine</s1>
<s3>JPN</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hertl, Michael" sort="Hertl, Michael" uniqKey="Hertl M" first="Michael" last="Hertl">Michael Hertl</name>
<affiliation><inist:fA14 i1="14"><s1>Universitätsklinikum GieBen und Marburg GmbH</s1>
<s3>DEU</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hunzelmann, Nico" sort="Hunzelmann, Nico" uniqKey="Hunzelmann N" first="Nico" last="Hunzelmann">Nico Hunzelmann</name>
<affiliation><inist:fA14 i1="15"><s1>Universitätshautklinik Köln</s1>
<s3>DEU</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Iranzo, Pilar" sort="Iranzo, Pilar" uniqKey="Iranzo P" first="Pilar" last="Iranzo">Pilar Iranzo</name>
<affiliation><inist:fA14 i1="16"><s1>Hospital Clínic, Universitat de Barcelona</s1>
<s3>ESP</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Joly, Pascal" sort="Joly, Pascal" uniqKey="Joly P" first="Pascal" last="Joly">Pascal Joly</name>
<affiliation><inist:fA14 i1="17"><s1>Clinique Dermatologique, Hopital Charles Nicolle</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>17 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Jonkman, Marcel F" sort="Jonkman, Marcel F" uniqKey="Jonkman M" first="Marcel F." last="Jonkman">Marcel F. Jonkman</name>
<affiliation><inist:fA14 i1="18"><s1>University Medical Center Groningen, University of Groningen</s1>
<s3>NLD</s3>
<sZ>18 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kitajima, Yasuo" sort="Kitajima, Yasuo" uniqKey="Kitajima Y" first="Yasuo" last="Kitajima">Yasuo Kitajima</name>
<affiliation><inist:fA14 i1="19"><s1>Gifu University School of Medicine</s1>
<s3>JPN</s3>
<sZ>19 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Korman, Neil J" sort="Korman, Neil J" uniqKey="Korman N" first="Neil J." last="Korman">Neil J. Korman</name>
<affiliation><inist:fA14 i1="20"><s1>University Hospitals Case Medical Center</s1>
<s2>Cleveland</s2>
<s3>USA</s3>
<sZ>20 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Martin, Linda K" sort="Martin, Linda K" uniqKey="Martin L" first="Linda K." last="Martin">Linda K. Martin</name>
<affiliation><inist:fA14 i1="01"><s1>Departments of Dermatology at St George Hospital, University of NSW</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>21 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mimouni, Daniel" sort="Mimouni, Daniel" uniqKey="Mimouni D" first="Daniel" last="Mimouni">Daniel Mimouni</name>
<affiliation><inist:fA14 i1="21"><s1>Rabin Medical Center</s1>
<s2>Petah-Tikva</s2>
<s3>ISR</s3>
<sZ>22 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Pandya, Amit G" sort="Pandya, Amit G" uniqKey="Pandya A" first="Amit G." last="Pandya">Amit G. Pandya</name>
<affiliation><inist:fA14 i1="22"><s1>University of Texas Southwestern Medical Center</s1>
<s2>Dallas</s2>
<s3>USA</s3>
<sZ>23 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Payne, Aimee S" sort="Payne, Aimee S" uniqKey="Payne A" first="Aimee S." last="Payne">Aimee S. Payne</name>
<affiliation><inist:fA14 i1="02"><s1>University of Pennsylvania</s1>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>24 aut.</sZ>
<sZ>30 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rubenstein, David" sort="Rubenstein, David" uniqKey="Rubenstein D" first="David" last="Rubenstein">David Rubenstein</name>
<affiliation><inist:fA14 i1="09"><s1>University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
<sZ>25 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Shimizu, Hiroshi" sort="Shimizu, Hiroshi" uniqKey="Shimizu H" first="Hiroshi" last="Shimizu">Hiroshi Shimizu</name>
<affiliation><inist:fA14 i1="23"><s1>Hokkaido University Graduate School of Medicine</s1>
<s2>Sapporo</s2>
<s3>JPN</s3>
<sZ>26 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sinha, Animesh A" sort="Sinha, Animesh A" uniqKey="Sinha A" first="Animesh A." last="Sinha">Animesh A. Sinha</name>
<affiliation><inist:fA14 i1="24"><s1>Center for Investigative Dermatology, Division of Dermatology and Cutaneous Sciences, Michigan State University</s1>
<s2>East Lansing</s2>
<s3>USA</s3>
<sZ>27 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sirois, David" sort="Sirois, David" uniqKey="Sirois D" first="David" last="Sirois">David Sirois</name>
<affiliation><inist:fA14 i1="25"><s1>Department of Oral Medicine, New York University College of Dentistry</s1>
<s3>USA</s3>
<sZ>28 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Zillikens, Detlef" sort="Zillikens, Detlef" uniqKey="Zillikens D" first="Detlef" last="Zillikens">Detlef Zillikens</name>
</author>
<author><name sortKey="Werth, Victoria P" sort="Werth, Victoria P" uniqKey="Werth V" first="Victoria P." last="Werth">Victoria P. Werth</name>
<affiliation><inist:fA14 i1="02"><s1>University of Pennsylvania</s1>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>24 aut.</sZ>
<sZ>30 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of the American Academy of Dermatology</title>
<title level="j" type="abbreviated">J. Am. Acad. Dermatol.</title>
<idno type="ISSN">0190-9622</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of the American Academy of Dermatology</title>
<title level="j" type="abbreviated">J. Am. Acad. Dermatol.</title>
<idno type="ISSN">0190-9622</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Definition</term>
<term>Dermatology</term>
<term>End</term>
<term>Pemphigus</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Pemphigus</term>
<term>Définition</term>
<term>Extrémité</term>
<term>Traitement</term>
<term>Dermatologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Our scientific knowledge of pemphigus has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in pemphigus. A major obstacle in comparing therapeutic outcomes between centers is the lack of generally accepted definitions and measurements for the clinical evaluation of patients with pemphigus. Common terms and end points of pemphigus are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. This consensus statement from the International Pemphigus Committee represents 2 years of collaborative efforts to attain mutually acceptable common definitions for pemphigus. These should assist in development of consistent reporting of outcomes in future studies.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0190-9622</s0>
</fA01>
<fA02 i1="01"><s0>JAADDB</s0>
</fA02>
<fA03 i2="1"><s0>J. Am. Acad. Dermatol.</s0>
</fA03>
<fA05><s2>58</s2>
</fA05>
<fA06><s2>6</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>MURRELL (Dedee F.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>DICK (Sarah)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>AHMED (A. R.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>AMAGAI (Masayuki)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>BARNADAS (Maria A.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>BORRADORI (Luca)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>BYSTRYN (Jean-Claude)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>CIANCHINI (Giuseppe)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>DIAZ (Luis)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>FIVENSON (David)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>HALL (Russell)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>HARMAN (Karen E.)</s1>
</fA11>
<fA11 i1="13" i2="1"><s1>HASHIMOTO (Takashi)</s1>
</fA11>
<fA11 i1="14" i2="1"><s1>HERTL (Michael)</s1>
</fA11>
<fA11 i1="15" i2="1"><s1>HUNZELMANN (Nico)</s1>
</fA11>
<fA11 i1="16" i2="1"><s1>IRANZO (Pilar)</s1>
</fA11>
<fA11 i1="17" i2="1"><s1>JOLY (Pascal)</s1>
</fA11>
<fA11 i1="18" i2="1"><s1>JONKMAN (Marcel F.)</s1>
</fA11>
<fA11 i1="19" i2="1"><s1>KITAJIMA (Yasuo)</s1>
</fA11>
<fA11 i1="20" i2="1"><s1>KORMAN (Neil J.)</s1>
</fA11>
<fA11 i1="21" i2="1"><s1>MARTIN (Linda K.)</s1>
</fA11>
<fA11 i1="22" i2="1"><s1>MIMOUNI (Daniel)</s1>
</fA11>
<fA11 i1="23" i2="1"><s1>PANDYA (Amit G.)</s1>
</fA11>
<fA11 i1="24" i2="1"><s1>PAYNE (Aimee S.)</s1>
</fA11>
<fA11 i1="25" i2="1"><s1>RUBENSTEIN (David)</s1>
</fA11>
<fA11 i1="26" i2="1"><s1>SHIMIZU (Hiroshi)</s1>
</fA11>
<fA11 i1="27" i2="1"><s1>SINHA (Animesh A.)</s1>
</fA11>
<fA11 i1="28" i2="1"><s1>SIROIS (David)</s1>
</fA11>
<fA11 i1="29" i2="1"><s1>ZILLIKENS (Detlef)</s1>
</fA11>
<fA11 i1="30" i2="1"><s1>WERTH (Victoria P.)</s1>
</fA11>
<fA14 i1="01"><s1>Departments of Dermatology at St George Hospital, University of NSW</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>21 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>University of Pennsylvania</s1>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>24 aut.</sZ>
<sZ>30 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Medicine, Center for Blistering Diseases, New England Baptist Hospital</s1>
<s2>Boston</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Keio University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Hospital de la Santa Creu i Sant Pau</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Hôpital Cantonal Universitaire</s1>
<s2>Geneva</s2>
<s3>CHE</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>New York University Medical Center</s1>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Immunodermatology Department, Istituto Dermopatico dell'lmmacolata, I.R.C.C.S., Via dei Monti di Creta</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
<sZ>25 aut.</sZ>
</fA14>
<fA14 i1="10"><s1>Private Practice</s1>
<s2>Ann Arbor</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="11"><s1>Division of Dermatology, Duke Medical Center</s1>
<s2>Durham</s2>
<s3>USA</s3>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="12"><s1>University Hospitals Leicester</s1>
<s3>GBR</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="13"><s1>Kurume University School of Medicine</s1>
<s3>JPN</s3>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="14"><s1>Universitätsklinikum GieBen und Marburg GmbH</s1>
<s3>DEU</s3>
<sZ>14 aut.</sZ>
</fA14>
<fA14 i1="15"><s1>Universitätshautklinik Köln</s1>
<s3>DEU</s3>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="16"><s1>Hospital Clínic, Universitat de Barcelona</s1>
<s3>ESP</s3>
<sZ>16 aut.</sZ>
</fA14>
<fA14 i1="17"><s1>Clinique Dermatologique, Hopital Charles Nicolle</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>17 aut.</sZ>
</fA14>
<fA14 i1="18"><s1>University Medical Center Groningen, University of Groningen</s1>
<s3>NLD</s3>
<sZ>18 aut.</sZ>
</fA14>
<fA14 i1="19"><s1>Gifu University School of Medicine</s1>
<s3>JPN</s3>
<sZ>19 aut.</sZ>
</fA14>
<fA14 i1="20"><s1>University Hospitals Case Medical Center</s1>
<s2>Cleveland</s2>
<s3>USA</s3>
<sZ>20 aut.</sZ>
</fA14>
<fA14 i1="21"><s1>Rabin Medical Center</s1>
<s2>Petah-Tikva</s2>
<s3>ISR</s3>
<sZ>22 aut.</sZ>
</fA14>
<fA14 i1="22"><s1>University of Texas Southwestern Medical Center</s1>
<s2>Dallas</s2>
<s3>USA</s3>
<sZ>23 aut.</sZ>
</fA14>
<fA14 i1="23"><s1>Hokkaido University Graduate School of Medicine</s1>
<s2>Sapporo</s2>
<s3>JPN</s3>
<sZ>26 aut.</sZ>
</fA14>
<fA14 i1="24"><s1>Center for Investigative Dermatology, Division of Dermatology and Cutaneous Sciences, Michigan State University</s1>
<s2>East Lansing</s2>
<s3>USA</s3>
<sZ>27 aut.</sZ>
</fA14>
<fA14 i1="25"><s1>Department of Oral Medicine, New York University College of Dentistry</s1>
<s3>USA</s3>
<sZ>28 aut.</sZ>
</fA14>
<fA20><s1>1043-1046</s1>
</fA20>
<fA21><s1>2008</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>18387</s2>
<s5>354000195963870150</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2008 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>1 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>08-0281029</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Journal of the American Academy of Dermatology</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Our scientific knowledge of pemphigus has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in pemphigus. A major obstacle in comparing therapeutic outcomes between centers is the lack of generally accepted definitions and measurements for the clinical evaluation of patients with pemphigus. Common terms and end points of pemphigus are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. This consensus statement from the International Pemphigus Committee represents 2 years of collaborative efforts to attain mutually acceptable common definitions for pemphigus. These should assist in development of consistent reporting of outcomes in future studies.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B08E</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B01</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Pemphigus</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Pemphigus</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Pénfigo</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Définition</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Definition</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Definición</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Extrémité</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>End</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Extremidad</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Traitement</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Treatment</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Dermatologie</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Dermatology</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Dermatología</s0>
<s5>12</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Maladie autoimmune</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Autoimmune disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Enfermedad autoinmune</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Dermatose bulleuse</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Bullous dermatosis</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Dermatosis bulosa</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Pathologie de la peau</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Skin disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Piel patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Immunopathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Immunopathology</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Inmunopatología</s0>
<s5>40</s5>
</fC07>
<fN21><s1>175</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 08-0281029 INIST</NO>
<ET>Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus</ET>
<AU>MURRELL (Dedee F.); DICK (Sarah); AHMED (A. R.); AMAGAI (Masayuki); BARNADAS (Maria A.); BORRADORI (Luca); BYSTRYN (Jean-Claude); CIANCHINI (Giuseppe); DIAZ (Luis); FIVENSON (David); HALL (Russell); HARMAN (Karen E.); HASHIMOTO (Takashi); HERTL (Michael); HUNZELMANN (Nico); IRANZO (Pilar); JOLY (Pascal); JONKMAN (Marcel F.); KITAJIMA (Yasuo); KORMAN (Neil J.); MARTIN (Linda K.); MIMOUNI (Daniel); PANDYA (Amit G.); PAYNE (Aimee S.); RUBENSTEIN (David); SHIMIZU (Hiroshi); SINHA (Animesh A.); SIROIS (David); ZILLIKENS (Detlef); WERTH (Victoria P.)</AU>
<AF>Departments of Dermatology at St George Hospital, University of NSW/Sydney/Australie (1 aut., 21 aut.); University of Pennsylvania/Etats-Unis (2 aut., 24 aut., 30 aut.); Department of Medicine, Center for Blistering Diseases, New England Baptist Hospital/Boston/Etats-Unis (3 aut.); Keio University School of Medicine/Tokyo/Japon (4 aut.); Hospital de la Santa Creu i Sant Pau/Barcelona/Espagne (5 aut.); Hôpital Cantonal Universitaire/Geneva/Suisse (6 aut.); New York University Medical Center/Etats-Unis (7 aut.); Immunodermatology Department, Istituto Dermopatico dell'lmmacolata, I.R.C.C.S., Via dei Monti di Creta/Rome/Italie (8 aut.); University of North Carolina/Chapel Hill/Etats-Unis (9 aut., 25 aut.); Private Practice/Ann Arbor/Etats-Unis (10 aut.); Division of Dermatology, Duke Medical Center/Durham/Etats-Unis (11 aut.); University Hospitals Leicester/Royaume-Uni (12 aut.); Kurume University School of Medicine/Japon (13 aut.); Universitätsklinikum GieBen und Marburg GmbH/Allemagne (14 aut.); Universitätshautklinik Köln/Allemagne (15 aut.); Hospital Clínic, Universitat de Barcelona/Espagne (16 aut.); Clinique Dermatologique, Hopital Charles Nicolle/Rouen/France (17 aut.); University Medical Center Groningen, University of Groningen/Pays-Bas (18 aut.); Gifu University School of Medicine/Japon (19 aut.); University Hospitals Case Medical Center/Cleveland/Etats-Unis (20 aut.); Rabin Medical Center/Petah-Tikva/Israël (22 aut.); University of Texas Southwestern Medical Center/Dallas/Etats-Unis (23 aut.); Hokkaido University Graduate School of Medicine/Sapporo/Japon (26 aut.); Center for Investigative Dermatology, Division of Dermatology and Cutaneous Sciences, Michigan State University/East Lansing/Etats-Unis (27 aut.); Department of Oral Medicine, New York University College of Dentistry/Etats-Unis (28 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Journal of the American Academy of Dermatology; ISSN 0190-9622; Coden JAADDB; Etats-Unis; Da. 2008; Vol. 58; No. 6; Pp. 1043-1046; Bibl. 1 ref.</SO>
<LA>Anglais</LA>
<EA>Our scientific knowledge of pemphigus has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in pemphigus. A major obstacle in comparing therapeutic outcomes between centers is the lack of generally accepted definitions and measurements for the clinical evaluation of patients with pemphigus. Common terms and end points of pemphigus are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. This consensus statement from the International Pemphigus Committee represents 2 years of collaborative efforts to attain mutually acceptable common definitions for pemphigus. These should assist in development of consistent reporting of outcomes in future studies.</EA>
<CC>002B08E; 002B01</CC>
<FD>Pemphigus; Définition; Extrémité; Traitement; Dermatologie</FD>
<FG>Maladie autoimmune; Dermatose bulleuse; Pathologie de la peau; Immunopathologie</FG>
<ED>Pemphigus; Definition; End; Treatment; Dermatology</ED>
<EG>Autoimmune disease; Bullous dermatosis; Skin disease; Immunopathology</EG>
<SD>Pénfigo; Definición; Extremidad; Tratamiento; Dermatología</SD>
<LO>INIST-18387.354000195963870150</LO>
<ID>08-0281029</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003542 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 003542 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:08-0281029
   |texte=   Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri